🦊/People

Stephen Chambers

Investor

General Partner at SOSV

New York, New York

Writes $100K – $2M checks · typically $1M

Find your path to Stephen

436 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.

AlptugunlockedStephen: together at Imperial College London (2021)
Stephen: together at Imperial College London
×6Stephen: together at SOSV
×4Stephen: together at University of Birmingham

About

Stephen Chambers is a General Partner at SOSV and Managing Director of SOSV NY, which he co-founded in 2020 after mentoring the program's life science startups since 2018. He holds a PhD in Molecular Biology and has extensive pharma entrepreneurship experience, having been a founding scientist at Vertex Pharmaceuticals, co-founded Abpro Therapeutics, and served as CEO of SynbiCITE and co-founder of the UK accelerator Bio-start.

Experience

  1. SOSVManaging Director & General Partner at SOSV NYcurrent2020 — presentNew York, United States
  2. Imperial College LondonRoyal Society Entrepreneur in Residence2019 — 2021Greater London, England, United Kingdom
  3. Bio-startCo Founder2016 — 2018Greater London, England, United Kingdom
  4. SynbiCITECEO2014 — 2018Greater London, England, United Kingdom
  5. London DNA FoundryAdvisory Board Member2014 — 2018Greater London, England, United Kingdom
  6. AbproCo Founder2008 — 2013Lexington, MA, USA
  7. Vertex PharmaceuticalsDirector of Gene Expression1990 — 2007Cambridge, MA, USA

Skills & more

Mentoring1StartupsClinical DevelopmentProtein ExpressionProtein EngineeringMonoclonal AntibodiesBusiness DevelopmentAutomationDesign of Experiments (DOE)Technological InnovationSynthetic BiologyProject Mangement
+12 moreInvestmentFundraisingInvestmentsBiochemistryBiotechnologyProtein ChemistryMolecular BiologyDrug DiscoveryStart-upsCell CultureLifesciencesCell Biology

From Stephen's professional profile.

Investments

Investor

5h45AIMAAnomer BioArgentagAromatEcoAsta BioAthos BioindustriesAvantGuardBacteryBasin GenomicsBeemmunityBioeutecticsBioFluffBioLatticeBiomageBosque FoodsBrickBuilt TherapeuticsBrightCureBucha BioBugBiomeCalder BiosciencesCapro-XCare ConstitutionCayuga BiotechCell BioEnginesCellCodexCeragenCircadianConan MedTechCroBioDeep Root BiolabsDipteraEachdayEarnest AgricultureEdge FoodsFluoSpheraForage EvolutionForte ProteinFoundational BioFree to FeedFREZENTGiraffe Bioharmony baby nutritionHelexHexem BioInnatrixInso BiosciencesiOrganBioJanusKalia HealthKlona BiotechKolibriKutaniosKyomeiLizarBio TherapeuticsLux BioMateria BioworksmicroTERRAMoonlight TherapeuticsMothership MaterialsMultusNanoPlumeNat4BioNukokoPalate TherapeuticsPannex Therapeutics Inc.PneumaPrimary BioscienceQuorum EarthRizlab HealthSable TherapeuticsSci-Lume LabsSemionSEQUENTIALStarstone BiomaterialsStembionixTastee TapeTerra Bioindustries Inc.TesaraktTinkeso TherapeuticsTômtexUprightVader NanotechnologiesVine MedicalVitarka TherapeuticsXias Bio

Per curated public sources.

Colleagues at SOSV

Network2

Investors connected to Stephen in public investor directories — a warm-intro map.

Frequently asked questions

Who is Stephen Chambers?
Stephen Chambers is a General Partner at SOSV and Managing Director of SOSV NY, which he co-founded in 2020 after mentoring the program's life science startups since 2018. He holds a PhD in Molecular Biology and has extensive pharma entrepreneurship experience, having been a founding scientist at Vertex Pharmaceuticals, co-founded Abpro Therapeutics, and served as CEO of SynbiCITE and co-founder of the UK accelerator Bio-start.
Where does Stephen Chambers work?
Stephen Chambers is General Partner at SOSV.
What check size does Stephen Chambers write?
Stephen Chambers typically writes checks of $100K – $2M.
What companies has Stephen Chambers invested in?
Investments tracked here include 5h45, AIMA, Anomer Bio, Argentag, AromatEco, Asta Bio, Athos Bioindustries, AvantGuard, Bactery, Basin Genomics, Beemmunity, Bioeutectics, and 74 more.
Where did Stephen Chambers go to school?
Stephen Chambers studied at University of Warwick (PhD, Molecular Biology); University of Birmingham (MS, Biotechnology); Bangor University (BS, Biochemistry).

Same school

Shared employers